GENinCode Plc (LON:GENI – Get Free Report)’s stock price was up 16.7% during mid-day trading on Wednesday . The stock traded as high as GBX 7.44 ($0.09) and last traded at GBX 7.44 ($0.09). Approximately 218,352 shares changed hands during mid-day trading, a decline of 23% from the average daily volume of 283,120 shares. The stock had previously closed at GBX 6.38 ($0.08).
GENinCode Price Performance
The firm has a market capitalization of £13.27 million, a PE ratio of -118.75 and a beta of 0.62. The company has a debt-to-equity ratio of 6.74, a current ratio of 5.92 and a quick ratio of 15.89. The firm has a 50-day simple moving average of GBX 8.01 and a 200-day simple moving average of GBX 5.97.
About GENinCode
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
Read More
- Five stocks we like better than GENinCode
- Dividend Payout Ratio Calculator
- Dave & Buster’s Stock Offers a Prime Buying Opportunity
- What is Put Option Volume?
- The FOMC Decision Means Higher Prices for Stocks This Summer
- The How And Why of Investing in Oil Stocks
- Here’s Why Analysts Boosted Walmart Stock’s Valuation
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
